查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587418

美国药品分析测试外包市场规模、份额、趋势分析报告：按服务、最终用途、地区和细分市场预测，2025-2030 年

U.S. Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Services, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

美国药物分析测试外包市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，美国药品分析测试外包市场规模预计将达50.9亿美元。

预计2025年至2030年该市场将以8.5%的复合年增长率扩张。医疗保健产业的技术进步和最终用户数量的增加是推动美国市场成长的主要因素。

药物分析业务，业务使他们能够专注于自己的核心能力。医疗机构可以避免开发专门设施和僱用员工，从而节省成本。药物分析测试涉及药品和治疗溶液中成分的识别和测量。由于研发投资增加和药品需求增加，预计市场在评估期内将扩大。

药物分析测试外包受到了 COVID-19 疫情的严重影响。药物分析服务是医疗保健基础设施的重要组成部分，最初由于各製药公司内部实验室的测试能力减少或关闭而受到干扰。工作人员最初面临多项挑战，包括因担心病毒传播而导致实验室能力下降、IT 问题以及发送样本进行测试困难等。然而，公司已经采取了各种策略来减少或防止这些困难，例如轮班、缩小规模和在家工作。

多家公司透过创建各种尖端测试和解决方案来支持政府遏制 COVID-19 大流行的努力。这些公司能够减少 COVID-19对其营运的影响。例如，Eurofins Laboratories 已成功生产了 4,000 万份 COVID-19检测套组。此外，正在为不同的变体建立新的检测套组。当 WHO 将 COVID-19 列为值得关注的变体时，我们当天发布了 Omicron检测套组。

美国药物分析测试外包市场报告重点：

  • 随着生物製药行业的公司越来越多地在研发上投入资金并更喜欢外包分析测试，到 2024 年，生物分析测试行业将以 52.2% 的收入份额占据市场主导地位。
  • 在方法开发和验证领域，2024年提取和浸出服务占细分市场份额为23.55%。
  • 2024年，製药公司细分市场占比最大，为45.61%。有关体外和体内测试、先进技术和降低测试复杂性的创新方法的不断变化的法规是推动药物分析测试服务外包增加的一些因素。
  • West Pharmaceutical Services, Inc.、SGS SA、Eurofins Scientific、Pace Analytical Services Llc、Intertek Group Plc 是推动市场成长的主要企业。
  • 按最终用途划分，由于临床试验註册和市场进入数量的增加，生物製药公司预计将在预测期内实现最快的成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国药物分析测试外包市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国药品分析测试外包市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章美国药品分析测试外包市场：服务估算与趋势分析

  • 美国药物分析测试外包市场，依服务分类：细分仪表板
  • 美国药物分析测试外包市场，依服务分类：变异分析
  • 按服务划分，2018-2030
  • 生物分析测试
    • 生物分析测试市场，2018-2030
    • 临床
    • 非临床
  • 方法开发和检验
    • 方法开发与检验市场，2018-2030
    • 可萃取和可浸出
    • 杂质法
    • 技术咨询
    • 其他方法检验服务
  • 稳定性测试
    • 稳定性测试市场，2018-2030
    • 药物成分
    • 稳定性指标检验
    • 加速稳定性测试
    • 光稳定性测试
    • 其他稳定性测试方法
  • 其他检测服务
    • 其他测试服务市场，2018-2030

第五章美国药物分析测试外包市场：最终用途估算与趋势分析

  • 美国药物分析测试外包市场，依最终用途：细分仪表板
  • 按最终用途分類的美国药物分析测试外包市场：变化分析
  • 按最终用途划分，2018-2030
  • 製药公司
  • 生物製药公司
  • 合约调查机构

第六章 竞争状况

  • 市场参与企业分类
    • 创新者
    • 市场领导者
    • 新兴企业
    • 2024 年企业市场占有率分析
  • 公司简介
    • West Pharmaceutical Services, Inc.
    • SGS SA
    • Eurofins Scientific
    • Pace Analytical Services Llc
    • Intertek Group PLC
    • Pharmaceutical Product Development, LLC.
    • Wuxi Apptec, Inc.
    • Boston Analytical
    • Charles River Laboratories International, Inc.
Product Code: GVR-4-68039-189-7

U.S. Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends:

The U.S. pharmaceutical analytical testing outsourcing market size is expected to reach USD 5.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 8.5% from 2025 to 2030. Technological advancements in the healthcare industry and an increase in end-users are the key factors driving the growth of the U.S. market.

Analytical testing services outsourcing allows companies to handle more complex or repetitive tasks while also assisting companies in concentrating on their core competencies. Enabling medical organizations to avoid developing specialized facilities and hiring staff, results in cost savings. The identification and measurement of ingredients in drugs or therapeutic solutions are included in pharmaceutical analytical testing. The market is anticipated to expand during the assessment period as a result of rising R&D investments and rising drug demand.

The outsourcing of pharmaceutical analytical testing has been significantly impacted by the COVID-19 pandemic. Due to various pharmaceutical companies' internal lab testing capacities being reduced or shut down, the pharmaceutical analytical services-an important component of the healthcare infrastructure-were initially disrupted. The workers initially faced several difficulties, including reduced lab capacity because of concerns about spreading the virus, IT issues, and difficulties sending samples for testing. However, various strategies, including rotating shifts, reducing manpower, and working from home, have been adopted by companies to mitigate or prevent these difficulties.

Various companies supported the government's efforts to stop the COVID-19 pandemic by producing various cutting-edge tests and solutions. These businesses were able to reduce the effects of COVID-19 on their operations. For example, 40 million COVID-19 tests were successfully manufactured by Eurofins laboratories. Additionally, new test kits are being created for various variants. When WHO classified it as a variant of concern, they released an omicron test kit the same day.

U.S. Pharmaceutical Analytical Testing Outsourcing Market Report Highlights:

  • The bioanalytical testing segment dominated the market with a revenue share of 52.2% in 2024 due to players in the biopharmaceutical industry spending money on R&D and a growing preference for outsourcing analytical testing.
  • By method development and validation segment, the extractable and leachable services held 23.55% segment share in 2024.
  • The pharmaceutical companies segment accounted for the largest share of 45.61% in 2024. Changing regulations for in vitro and in vivo tests, sophisticated technologies, and creative methods to reduce test complexity are some of the factors that are causing more pharmaceutical analytical testing services to be outsourced.
  • West Pharmaceutical Services, Inc., SGS SA, Eurofins Scientific, Pace Analytical Services Llc, and Intertek Group Plc are some of the major key players contributing to the growth of the market.
  • Based on end-user, biopharmaceutical companies are anticipated to register the fastest growth over the forecast period due to an increase in the number of clinical trial registrations and market entrants.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Services
    • 1.2.2. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates And Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing innovation in testing services
      • 3.2.1.2. Growing regulation, safety & quality requirements
      • 3.2.1.3. Competitive Pricing Strategies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Data insecurity
      • 3.2.2.2. Third-party performance
  • 3.3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Pharmaceutical Analytical Testing Outsourcing Market: Services Estimates & Trend Analysis

  • 4.1. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Services: Segment Dashboard
  • 4.2. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Services: Movement Analysis
  • 4.3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By Services, 2018 - 2030
  • 4.4. Bioanalytical Testing
    • 4.4.1. Bioanalytical Testing Market, 2018 to 2030 (USD Million)
    • 4.4.2. Clinical
      • 4.4.2.1. Clinical Market, 2018 to 2030 (USD Million)
    • 4.4.3. Non- Clinical
      • 4.4.3.1. Non- Clinical Market, 2018 to 2030 (USD Million)
  • 4.5. Method Development and Validation
    • 4.5.1. Method Development and Validation Market, 2018 to 2030 (USD Million)
    • 4.5.2. Extractable and Leachable
      • 4.5.2.1. Extractable and Leachable Market, 2018 to 2030 (USD Million)
    • 4.5.3. Impurity Method
      • 4.5.3.1. Impurity Method Market, 2018 to 2030 (USD Million)
    • 4.5.4. Technical Consulting
      • 4.5.4.1. Technical Consulting Market, 2018 to 2030 (USD Million)
    • 4.5.5. Other Method Validation Services
      • 4.5.5.1. Other Method Validation Services Market, 2018 to 2030 (USD Million)
  • 4.6. Stability Testing
    • 4.6.1. Stability Testing Market, 2018 to 2030 (USD Million)
    • 4.6.2. Drug Substance
      • 4.6.2.1. Drug Substance Market, 2018 to 2030 (USD Million)
    • 4.6.3. Stability Indicating Method Validation
      • 4.6.3.1. Stability Indicating Method Validation Market, 2018 to 2030 (USD Million)
    • 4.6.4. Accelerated Stability Testing
      • 4.6.4.1. Accelerated Stability Testing Market, 2018 to 2030 (USD Million)
    • 4.6.5. Photostability Testing
      • 4.6.5.1. Photostability Testing Market, 2018 to 2030 (USD Million)
    • 4.6.6. Other Stability Testing Methods
      • 4.6.6.1. Other Stability Testing Methods Market, 2018 to 2030 (USD Million)
  • 4.7. Other Testing Services
    • 4.7.1. Other Testing Services Market, 2018 to 2030 (USD Million)

Chapter 5. U.S. Pharmaceutical Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis

  • 5.1. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Segment Dashboard
  • 5.2. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Movement Analysis
  • 5.3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030
  • 5.4. Pharmaceutical Companies
    • 5.4.1. Pharmaceutical Companies Market, 2018 to 2030 (USD Million)
  • 5.5. Biopharmaceutical Companies
    • 5.5.1. Biopharmaceutical Companies Market, 2018 to 2030 (USD Million)
  • 5.6. Contract Research Organizations
    • 5.6.1. Contract Research Organizations Market, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
    • 6.1.1. Innovators
    • 6.1.2. Market Leaders
    • 6.1.3. Emerging Players
    • 6.1.4. Company Market Share Analysis, 2024
  • 6.2. Company Profiles
    • 6.2.1. West Pharmaceutical Services, Inc.
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Financial Performance
      • 6.2.1.3. Service Benchmarking
      • 6.2.1.4. Strategic Initiatives
    • 6.2.2. SGS SA
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Financial Performance
      • 6.2.2.3. Service Benchmarking
      • 6.2.2.4. Strategic Initiatives
    • 6.2.3. Eurofins Scientific
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Financial Performance
      • 6.2.3.3. Service Benchmarking
      • 6.2.3.4. Strategic Initiatives
    • 6.2.4. Pace Analytical Services Llc
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Financial Performance
      • 6.2.4.3. Service Benchmarking
      • 6.2.4.4. Strategic Initiatives
    • 6.2.5. Intertek Group PLC
      • 6.2.5.1. Company Overview
      • 6.2.5.2. Financial Performance
      • 6.2.5.3. Service Benchmarking
      • 6.2.5.4. Strategic Initiatives
    • 6.2.6. Pharmaceutical Product Development, LLC.
      • 6.2.6.1. Company Overview
      • 6.2.6.2. Financial Performance
      • 6.2.6.3. Service Benchmarking
      • 6.2.6.4. Strategic Initiatives
    • 6.2.7. Wuxi Apptec, Inc.
      • 6.2.7.1. Company Overview
      • 6.2.7.2. Financial Performance
      • 6.2.7.3. Service Benchmarking
      • 6.2.7.4. Strategic Initiatives
    • 6.2.8. Boston Analytical
      • 6.2.8.1. Company Overview
      • 6.2.8.2. Financial Performance
      • 6.2.8.3. Service Benchmarking
      • 6.2.8.4. Strategic Initiatives
    • 6.2.9. Charles River Laboratories International, Inc.
      • 6.2.9.1. Company Overview
      • 6.2.9.2. Financial Performance
      • 6.2.9.3. Service Benchmarking
      • 6.2.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 1 List of Abbreviations
  • Table 2 U.S. Pharmaceutical Analytical Testing Outsourcing Market, by Services, 2018 - 2030 (USD Million)
  • Table 3 U.S. Pharmaceutical Analytical Testing Outsourcing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Pharmaceutical Analytical Testing Outsourcing Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 U.S. Pharmaceutical Analytical Testing Outsourcing Market snapshot
  • Fig. 11 U.S. Pharmaceutical Analytical Testing Outsourcing Market driver impact
  • Fig. 12 U.S. Pharmaceutical Analytical Testing Outsourcing Market restraint impact
  • Fig. 13 U.S. Pharmaceutical Analytical Testing Outsourcing Services Key Takeaways (USD Million)
  • Fig. 14 U.S. Pharmaceutical Analytical Testing Outsourcing Market: Services movement analysis
  • Fig. 15 Bioanalytical Testing Market, 2018 - 2030 (USD Million)
  • Fig. 16 Clinical Market, 2018 - 2030 (USD Million)
  • Fig. 17 Non- Clinical Market, 2018 - 2030 (USD Million)
  • Fig. 18 Method Development and Validation Market, 2018 - 2030 (USD Million)
  • Fig. 19 Extractable and Leachable Market, 2018 - 2030 (USD Million)
  • Fig. 20 Impurity Method Market, 2018 - 2030 (USD Million)
  • Fig. 21 Technical Consulting Market, 2018 - 2030 (USD Million)
  • Fig. 22 Other Method Validation Services Market, 2018 - 2030 (USD Million)
  • Fig. 23 Stability Testing Market, 2018 - 2030 (USD Million)
  • Fig. 24 Drug Substance Market, 2018 - 2030 (USD Million)
  • Fig. 25 Stability Indicating Method Validation Market, 2018 - 2030 (USD Million)
  • Fig. 26 Accelerated Stability Testing Market, 2018 - 2030 (USD Million)
  • Fig. 27 Photostability Testing Market, 2018 - 2030 (USD Million)
  • Fig. 28 Other Stability Testing Methods Market, 2018 - 2030 (USD Million)
  • Fig. 29 Other Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Pharmaceutical Analytical Testing Outsourcing Market End Use key takeaways (USD Million)
  • Fig. 31 U.S. Pharmaceutical Analytical Testing Outsourcing Market: End Use movement analysis
  • Fig. 32 Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • Fig. 33 Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • Fig. 34 Contract Research Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 35 Market participant categorization